Human Anti-Human VEGF Recombinant Antibody; Fab Fragment (TP-104CL) (CAT#: TP-104CL)
This product is a recombinant humanized IgG1 kappa isotype monoclonal antibody fragment designed for intraocular use. The antibody binds to and inhibits the biologic activity of human vascular endothelial growth factor A (VEGF-A). It has a molecular weight of approximately 48 kilodaltons and is produced by an E. coli expression system in a nutrient medium containing the antibiotic tetracycline (tetracycline is not detectable in the final product).
Specific Inquiry
Custom Production
We specialize in custom recombinant antibody production, offering seamless execution from provided sequences to high-quality antibody deliverables, ensuring optimal yield and purity.
We require custom production
WB
Figure 1 Anti-Human VEGF Antibody Fab Fragment (TP-104CL) in WB
Western blot analysis of TP-104CL was performed with Recombinant Human VEGF protein onto a 12% Tris-HCl polyacrylamide gel. Proteins were transferred to a CN membrane and blocked with 5% skim milk for at least one hour. Membranes were probed with TP-104CL and HRP Goat Anti-Human IgG as a secondary antibody. Chemiluminescent detection was performed.
ELISA
Figure 2 Anti-Human VEGF Antibody Fab Fragment (TP-104CL) in ELISA
ELISA analysis of TP-104CL was performed by coating with Recombinant Human VEGF Protein. Then blocked with BSA, and incubated with Anti-VEGF Therapeutic Antibody (ranibizumab) (TP-104CL). The HRP-conjugated goat anti-human IgG as a secondary antibody. Detection was performed using TMB substrate and stopped with sulfuric acid. The absorbances were read on a spectrophotometer at 450 nm.
DB
Figure 3 Anti-Human VEGF Antibody Fab Fragment (TP-104CL) in DB
Antigen: Human VEGF protein
Antibody incubation concentration: 2ng/μL.
Specifications
- Type
- Biotech
Target
- Function
- Humanized mAb fragment that binds isoforms of vascular endothelial growth factor A (VEGFA)
Related Resources
Please refer to Ranibizumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Ranibizumab.
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
Customer Reviews and Q&As
Customer Review
Q&As
Excellent for VEGF Studies
This Fab fragment has dramatically improved our experiments involving VEGF detection. Its high specificity and consistent performance in ELISA assays allow us to quantify VEGF levels precisely, providing invaluable data for our angiogenesis-related research projects.
Essential for Angiogenesis Research
Utilizing this antibody, we're able to dissect the molecular underpinnings of angiogenesis comprehensively. The Fab fragment's exacting binding to VEGF-A ensures we gain accurate insights into its role within tumor growth models, aiding in the identification of novel anti-angiogenic strategies.
Valuable Research Asset
Our studies of VEGF-mediated pathways have greatly benefited from this Fab fragment. It consistently facilitates accurate and reproducible results in our ELISA and Dot Blot assays, making it an indispensable asset for any project focused on vascular biology.
Cite This Product
To accurately reference this product in your publication, please use the following citation information:
(Creative Biolabs Cat# TP-104CL, RRID: AB_3112056)
Copy citation
Popular products with customers
Application: IF, IP, Neut, FuncS, ELISA, FC, WB
Application: IP, IF, FuncS, FC, Neut, ELISA, ICC
Application: ELISA
Application: FuncS, Inhib, IP, ELISA
Application: ELISA, SPR, Inhib, FuncS
Application: ELISA, Inhib, FC
Application: Neut, ELISA, FuncS
Application: Neut, FC, IHC-Fr, IP, BA
Application: ELISA, IHC, FC, IP, IF, FuncS
Application: ELISA, IHC, FC, IP, IF, BL
For Research Use Only. Not For Clinical Use.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
